The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regressionJulia Miriam Weiss, Nadège Bercovici, Marion V. Guérin et al.|OncoImmunology|2017Cited by 110
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumorsMarion V. Guérin, Nadège Bercovici, Fabienne Régnier et al.|Nature Communications|2019Cited by 81
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumorsMarion V. Guérin, Nadège Bercovici, Fabienne Régnier et al.|RePEc: Research Papers in Economics|0Cited by 5
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapseMarion V. Guérin, Nadège Bercovici, Fabienne Régnier et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 2
Abstract A05: Biphasic anti-tumoral effect of a vascular-disrupting agent triggering STING and tumor regressionJulia Miriam Weiss, Nadège Bercovici, Marion V. Guérin et al.|Cancer Immunology Research|2017Cited by 0